Artificial intelligence for dementia prevention.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published Date:

Abstract

INTRODUCTION: A wide range of modifiable risk factors for dementia have been identified. Considerable debate remains about these risk factors, possible interactions between them or with genetic risk, and causality, and how they can help in clinical trial recruitment and drug development. Artificial intelligence (AI) and machine learning (ML) may refine understanding.

Authors

  • Danielle Newby
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
  • Vasiliki Orgeta
    Division of Psychiatry, University College London, London, UK.
  • Charles R Marshall
    Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; Neurology Department, Barts Health NHS Trust, London, UK. Electronic address: charles.marshall@qmul.ac.uk.
  • Ilianna Lourida
    University of Exeter Medical School, Exeter, UK.
  • Christopher P Albertyn
    Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Stefano Tamburin
    Neurology Section, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Vanessa Raymont
    University of Oxford, Oxford, UK.
  • Michele Veldsman
    Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
  • Ivan Koychev
    Senior Clinical Researcher, Department of Psychiatry, University of Oxford, Oxford, UK.
  • Sarah Bauermeister
    Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
  • David Weisman
    Abington Neurological Associates, Abington, Pennsylvania, USA.
  • Isabelle F Foote
    Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, USA.
  • Magda Bucholc
    Cognitive Analytics Research Lab, School of Computing, Engineering & Intelligent Systems, Ulster University, Derry, UK.
  • Anja K Leist
    Department of Social Sciences, Institute for Research on Socio-Economic Inequality (IRSEI), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Eugene Y H Tang
    Population Health Sciences Institute, Newcastle University, Newcastle, UK.
  • Xin You Tai
    Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK.
  • David J Llewellyn
    University of Exeter Medical School, Exeter, United Kingdom.
  • Janice M Ranson
    University of Exeter Medical School, Exeter, United Kingdom.